Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Acta Diabetologica|November 10, 2025
The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study groupVeronica Resi, Cristina Bianchi, Silvia Burlina, et al.
Nutrients|December 23, 2022
Association between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT StudyMarilena Vitale, Giuseppe Della Pepa, Giuseppina Costabile, et al.
Diabetology & Metabolic Syndrome|November 29, 2025
Impact of changes in diabetes care models and advanced technologies on two-year glycemic control after COVID-19 lockdown in adults with Type 1 DiabetesLutgarda Bozzetto, Roberta Lupoli, Maria Masulli, et al.
Diabetes Research and Clinical Practice|July 7, 2023
Insulin pump therapy in type 1 diabetes is associated with lower indices of Non-Alcoholic Fatty Liver in non-obese women but not menGiuseppe Della Pepa, Roberta Lupoli, Maria Masulli, et al.
Diabetes Research and Clinical Practice|July 26, 2021
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trialGiuseppe Della Pepa, Marco Russo, Marilena Vitale, et al.
Diabetes Research and Clinical Practice|August 23, 2020
Cardiovascular risk factors control according to diabetes status and prior cardiovascular events in patients managed in different settingsOlga Vaccaro, Marilena Vitale, Simona Costanzo, et al.
Diabetes/Metabolism Research and Reviews|April 1, 2024
Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic controlGiuseppe Della Pepa, Fabrizia Carli, Silvia Sabatini, et al.
Diabetes/Metabolism Research and Reviews|August 13, 2020
The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose-lowering drugs in patients with type 2 diabetesMaria Masulli, Giuseppe Della Pepa, Sara Cocozza, et al.
Diabetes Research and Clinical Practice|July 21, 2022
Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective studyNicola Tecce, Maria Masulli, Luisa Palmisano, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2019
Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized CareOlga Vaccaro, Giuseppe Lucisano, Maria Masulli, et al.
Pageof 6